Our study investigated whether qualitative imaging biomarkers for CDKN2A can be identified in glioblastomas on pre-operative MR images using standard imaging protocol, as this sub-classification of glioblastomas is currently not available. The gene discussed is CDKN2A; the disease is glioblastoma.